We use this information to make the website work as well as possible and improve our services.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you accept.
Helping families and friends share messages and photographs with patients in our hospitals.
MyChart - Keeping you involved and informed about your care.
Contact us - Commonly asked questions.
Just do it!
Just do it!
I lead the non-surgical melanoma and pancreatic cancer clinical teams at CUH.
Over the last 20 years, I have been closely involved in clinical trials which have led to the introduction of modern treatments for patients with melanoma and pancreaticobiliary cancers.
NIHR Cancer Research Network National Cancer Co-Lead, NCRI Pancreatic Cancer Workstream Chair, Trustee of the Melanoma Focus national charity, Medical Adviser to the Pancreatic Cancer UK charity
I enjoy my family life, running and playing the piano.
Wan JCM, Heider K, Gale D, Murphy S, Fisher E, Mouliere F, Ruiz-Valdepenas A, Santonja A, Morris J, Chandrananda D, Marshall A, Gill AB, Chan PY, Barker E, Young G, Cooper WN, Hudecova I, Marass F, Mair R, Brindle KM, Stewart GD, Abraham J, Caldas C, Rassl DM, Rintoul RC, Alifrangis C, Middleton MR, Gallagher FA, Parkinson C, Durrani A, McDermott U, Smith CG, Massie C, Corrie PG and Rosenfeld N. ctDNA monitoring using patient-specific sequencing and integration of variant reads. Sci Trans Med 2020; 12 (548) eaaz8084.
Welsh SJ and Corrie PG. Biomarkers predicting for response and relapse with melanoma systemic therapy. Acta Dermato-Venereol 2020; 100: 300-8.
Corrie PG, Qian W, Basu B, Valle JW, Falk S, lwuji C, Wasan H, Palmer D, Scott-Brown M, Wadsley J, Arif S, Bridgewater J, Propper D, Gillmore R, Gopinathan A, Skells R, Bundi R, Brais R, Dalchau K, Bax L, Chhabra A, Machin A, Dayim A, McAdam K, Cummins S, Wall L, Ellis R, Anthoney A, Evans J, Ma YT, Isherwood C, Neesse A, D Tuveson, Jodrell DI. Scheduling nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic adenocarcinoma. Br J Cancer 2020; 122: 1760-68.
PG Corrie, AM Moody, G Armstrong, S Nolasco, S Lao-Sirieix, L Bavister, AT Prevost, R Parker, R Sabes-Figuera, P McCrone, H Balsdon, K McKinnon, A Hounsell, B O’Sullivan, SIG Barclay. Is community treatment best? A randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery. Br J Cancer 2013; 109:1549-1555.
Corrie P, Matrisian L, Poon JO. Pancreatic cancer – current landscape. Oncol Hematol Rev (US) 2019;15 (Suppl.1)